Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

493 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Identifying optimal doses of heart failure medications in men compared with women: a prospective, observational, cohort study.
Santema BT, Ouwerkerk W, Tromp J, Sama IE, Ravera A, Regitz-Zagrosek V, Hillege H, Samani NJ, Zannad F, Dickstein K, Lang CC, Cleland JG, Ter Maaten JM, Metra M, Anker SD, van der Harst P, Ng LL, van der Meer P, van Veldhuisen DJ, Meyer S, Lam CSP; ASIAN-HF investigators; Voors AA. Santema BT, et al. Among authors: hillege h. Lancet. 2019 Oct 5;394(10205):1254-1263. doi: 10.1016/S0140-6736(19)31792-1. Epub 2019 Aug 22. Lancet. 2019. PMID: 31447116 Free article.
Comparison between New York Heart Association classification and peak oxygen consumption in the assessment of functional status and prognosis in patients with mild to moderate chronic congestive heart failure secondary to either ischemic or idiopathic dilated cardiomyopathy.
van den Broek SA, van Veldhuisen DJ, de Graeff PA, Landsman ML, Hillege H, Lie KI. van den Broek SA, et al. Among authors: hillege h. Am J Cardiol. 1992 Aug 1;70(3):359-63. doi: 10.1016/0002-9149(92)90619-a. Am J Cardiol. 1992. PMID: 1632403
Effects of spirapril and captopril on regional blood flow in chronic congestive heart failure: a comparison between a short- and a long-acting angiotensin-converting enzyme inhibitor.
van den Broek SA, de Graeff PA, Smit AJ, Girbes AR, Journée, van Gilst WH, Hillege H, van Veldhuisen DJ, Wesseling H, Lie KI. van den Broek SA, et al. Among authors: hillege h. J Cardiovasc Pharmacol. 1995 Jan;25(1):105-12. doi: 10.1097/00005344-199501000-00017. J Cardiovasc Pharmacol. 1995. PMID: 7723338 Clinical Trial.
493 results